Howard Fingert, M.D.
Senior Medical Director, Clinical Intelligence and Business Development
Dr. Fingert is senior medical director of clinical intelligence for Takeda Oncology in Cambridge, Massachusetts. He worked in the biotech/pharma industry for more than 20 years after serving in academic faculty positions at Harvard and Tufts medical schools. He has published experience in cancer biomarkers, pharmacology, clinical safety risk management and phases 1-4 clinical trials.
In addition to cross-functional industry experience in clinical development, regulatory affairs and business development, Dr. Fingert has been engaged in public-private partnerships with academic centers, Biden Moonshot initiatives and the National Cancer Institute, and he recently served as industry representative to the Oncology Drugs Advisory Committee of the U.S. Food and Drug Administration.